Literature DB >> 14978675

Normal dopaminergic and serotonergic metabolites in cerebrospinal fluid and blood of restless legs syndrome patients.

Karin Stiasny-Kolster1, J Carsten Möller, Johannes Zschocke, Oliver Bandmann, Werner Cassel, Wolfgang H Oertel, Georg F Hoffmann.   

Abstract

Cerebrospinal fluid (CSF) and blood obtained from 22 untreated or scarcely treated patients with moderate to severe restless legs syndrome (RLS; mean age, 58.6 +/- 13 years) and 11 control subjects (mean age, 56.6 +/- 12.9 years) were investigated for biogenic amines between 6:00 and 8:00 PM. We did not find any significant differences in the CSF concentrations of homovanillic acid, 3-ortho- methyl-dopa, levodopa, 5-hydroxytryptophan, 5-hydroxyindoleacetic acid, tetrahydrobiopterin, dihydrobiopterin, 5-methyltetrahydrofolate, and neopterin. In addition, serotonin in whole blood and plasma activity of aromatic amino acid decarboxylase were all normal. Our results suggest that dopaminergic and serotonergic release is not substantially affected in RLS.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14978675     DOI: 10.1002/mds.10631

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  13 in total

1.  Periodic leg movements in sleep in elderly patients with Parkinsonism and Alzheimer's disease.

Authors:  D L Bliwise; L M Trotti; J A Yesavage; D B Rye
Journal:  Eur J Neurol       Date:  2012-02-16       Impact factor: 6.089

2.  The dopamine transporter is decreased in the striatum of subjects with restless legs syndrome.

Authors:  Christopher J Earley; Hiroto Kuwabara; Dean F Wong; Charlene Gamaldo; Rachel Salas; James Brasic; Hayden T Ravert; Robert F Dannals; Richard P Allen
Journal:  Sleep       Date:  2011-03-01       Impact factor: 5.849

Review 3.  Restless legs syndrome--new insights into clinical characteristics, pathophysiology, and treatment options.

Authors:  K Stiasny-Kolster; C Trenkwalder; W Fogel; W Greulich; M Hahne; L Lachenmayer; M Oechsner; W H Oertel
Journal:  J Neurol       Date:  2004-09       Impact factor: 4.849

4.  Motor restlessness, sleep disturbances, thermal sensory alterations and elevated serum iron levels in Btbd9 mutant mice.

Authors:  Mark P DeAndrade; Russell L Johnson; Erica L Unger; Li Zhang; Thomas van Groen; Karen L Gamble; Yuqing Li
Journal:  Hum Mol Genet       Date:  2012-06-07       Impact factor: 6.150

Review 5.  Restless Leg Syndrome/Willis-Ekbom Disease Pathophysiology.

Authors:  Richard P Allen
Journal:  Sleep Med Clin       Date:  2015-07-15

6.  Abnormally increased CSF 3-Ortho-methyldopa (3-OMD) in untreated restless legs syndrome (RLS) patients indicates more severe disease and possibly abnormally increased dopamine synthesis.

Authors:  Richard P Allen; James R Connor; Keith Hyland; Christopher J Earley
Journal:  Sleep Med       Date:  2008-01-28       Impact factor: 3.492

7.  Altered dopaminergic profile in the putamen and substantia nigra in restless leg syndrome.

Authors:  James R Connor; Xin-Sheng Wang; Richard P Allen; John L Beard; Jason A Wiesinger; Barbara T Felt; Christopher J Earley
Journal:  Brain       Date:  2009-05-25       Impact factor: 13.501

8.  Pramipexole in restless legs syndrome: an evidence-based review of its effectiveness on clinical outcomes.

Authors:  William Winlow
Journal:  Core Evid       Date:  2005-03-31

Review 9.  Restless Legs Syndrome: Current Concepts about Disease Pathophysiology.

Authors:  Brian B Koo; Kanika Bagai; Arthur S Walters
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2016-07-22

Review 10.  Restless Legs Syndrome and Parkinson Disease: A Causal Relationship Between the Two Disorders?

Authors:  Luigi Ferini-Strambi; Giulia Carli; Francesca Casoni; Andrea Galbiati
Journal:  Front Neurol       Date:  2018-07-24       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.